VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,205,000 | -69.8% | 350,000 | +16.7% | 3.26% | -51.6% |
| Q4 2015 | $30,495,000 | -46.2% | 300,000 | -5.5% | 6.74% | -45.6% |
| Q3 2015 | $56,647,000 | -75.4% | 317,561 | -69.4% | 12.38% | -43.7% |
| Q2 2015 | $230,599,000 | +11.8% | 1,038,033 | -0.0% | 21.97% | -24.2% |
| Q1 2015 | $206,241,000 | +109.4% | 1,038,371 | +50.8% | 28.99% | +2.9% |
| Q4 2014 | $98,513,000 | +60.3% | 688,371 | +47.0% | 28.16% | +148.7% |
| Q3 2014 | $61,450,000 | -33.4% | 468,371 | -36.0% | 11.32% | -13.5% |
| Q2 2014 | $92,315,000 | +24.5% | 731,960 | +30.2% | 13.09% | -27.6% |
| Q1 2014 | $74,127,000 | +33.2% | 562,293 | +18.6% | 18.09% | +33.6% |
| Q4 2013 | $55,666,000 | -12.5% | 474,158 | -22.2% | 13.53% | -28.4% |
| Q3 2013 | $63,612,000 | +60.9% | 609,718 | +38.3% | 18.89% | -4.0% |
| Q2 2013 | $39,535,000 | – | 440,883 | – | 19.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |